AGIOS PHARMACEUTICALS, INC. Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.07 | 500 | 28,535 | 87,434 | 87.9 K to 87.4 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.07 | 500 | 28,535 | 87,394 | 87.9 K to 87.4 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.09 | 500 | 28,545 | 87,934 | 88.4 K to 87.9 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.09 | 500 | 28,545 | 87,894 | 88.4 K to 87.9 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.61 | 500 | 28,305 | 88,434 | 88.9 K to 88.4 K (-0.56 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.61 | 500 | 28,305 | 88,394 | 88.9 K to 88.4 K (-0.56 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.63 | 500 | 28,315 | 88,934 | 89.4 K to 88.9 K (-0.56 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.63 | 500 | 28,315 | 88,894 | 89.4 K to 88.9 K (-0.56 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 2,146 | 19,421 | 37,427 | |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 60.06 | 21,000 | 1,261,260 | 25,470 | 46.5 K to 25.5 K (-45.19 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 55.05 | 2,146 | 118,137 | 6,264 | 8.4 K to 6.3 K (-25.52 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 2,146 | 19,421 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 24,000 | 7,260 | 159,656 | |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 183,656 | |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 60.55 | 24,000 | 1,453,200 | 0 | 24 K to 0 (-100.00 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 24,000 | 7,260 | 24,000 | 0 to 24 K |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 55.12 | 3,000 | 165,360 | 0 | 3 K to 0 (-100.00 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 3,000 | 908 | 3,000 | 0 to 3 K |